Epidemiology of antimicrobial resistance in commensal Escherichia coli from healthy dairy cattle on a Mediterranean pasture-based system of Australia: A cross-sectional study

被引:0
作者
Tree, M. [1 ]
Lam, T. J. G. M. [2 ,3 ]
Mcdougall, S. [4 ]
Beggs, D. S. [5 ,6 ]
Robertson, I. D. [1 ]
Barnes, A. L. [1 ]
Chopra, A. [7 ]
Ram, R. [7 ]
Stockman, C. A. [1 ]
Kent, T. C. [1 ]
Aleri, J. W. [1 ,8 ,9 ]
机构
[1] Murdoch Univ, Coll Sci Hlth Engn & Educ, Sch Vet Med, Murdoch, WA 6150, Australia
[2] Univ Utrecht, GD Anim Hlth, Deventer, NL-3584 CS Utrecht, Netherlands
[3] Univ Utrecht, Fac Vet Med, NL-3584 CS Utrecht, Netherlands
[4] Anexa Vet Serv, Cognosco, Morrinsville 3340, New Zealand
[5] Univ Melbourne, Fac Vet & Agr Sci, Anim Welf Sci Ctr, Parkville, Vic 3052, Australia
[6] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic 3030, Australia
[7] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia
[8] Murdoch Univ, Future Foods Inst, Ctr Anim Prod & Hlth, Murdoch, WA 6150, Australia
[9] Murdoch Univ, Harry Butler Inst, Murdoch, WA 6150, Australia
关键词
antimicrobial resistance; dairy calf; dairy cow; sampling populations; prevalence; POPULATIONS; SURVEILLANCE; GENES;
D O I
10.3168/jds.2024-25157
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
This study aimed to determine the prevalence of antimicrobial resistance (AMR) in commensal Escherichia coli from healthy lactating cows and calves in the Mediterranean pasture-based feeding dairy system of Western Australia (WA). Fecal samples were collected from healthy adult lactating cows and healthy calves from dairy farms in WA. Presumptive commensal E. coli was isolated from these samples and confirmed using matrix- assisted laser-desorption/ionization time-of-flight mass spectrometry. Broth microdilution was used to assess the prevalence and the phenotypic AMR profiles of the E. coli isolates to 8 antimicrobial agents of dairy industry and human importance. The minimum inhibitory concentration for each isolate was interpreted using the epidemiologic cutoff (ECOFF) and Clinical and Laboratory Standards Institute breakpoints. Genomic characterization provided multilocus sequence types and AMR genes for a selection of isolates categorized as nonwild type (NWT) by ECOFF values for the combination of ampicillin, trimethoprim-sulfamethoxazole, and tetracycline. From a total of 1,117 fecal samples (633 adult, 484 calf) collected across 26 randomly selected farms, 891 commensal E. coli isolates were recovered (541 adult, 350 calf). Commensal E. coli classified as NWT was highest for ampicillin for both adult (68.8%; 95% CI [64.7, 72.7]) and calf feces (67.1%; 95% CI [62.0, 72.0]). A large proportion of tetracycline NWT and trimethoprimsulfamethoxazole NWT organisms were also identified from calf feces, being 44.0% (95% CI [38.7, 49.4]) and 24.6% (95% CI [20.2, 29.4]), respectively. Clinical resistance prevalence was low, being higher for calves than for adult feces for ampicillin (adult: 7.8%, 95% CI [5.7, 10.3]; calf: 30.0%, 95% CI [25.2, 35.1]), tetracycline (adult: 6.3%, 95% CI [4.4, 8.7]; calf: 40.3%, 95% CI [35.1, 45.6]), and trimethoprim-sulfamethoxazole (adult: 2.6%, 95% CI [1.4, 4.3]; calf: 22.0%, 95% CI [17.7, 26.7]). Commensal E. coli originating from calf feces was significantly higher in NWT prevalence compared with adult feces for ciprofloxacin, gentamicin, tetracycline, and trimethoprim-sulfamethoxazole. The overall number of antimicrobials an isolate was classified as NWT toward varied among farms and was significantly higher for isolates originating from calf rather than adult feces. The strain type and sampling source of the commensal E. coli investigated were both associated with the commonality of the resultant resistance genome. Clinical resistance and NWT classification were highest for ampicillin, tetracycline, and trimethoprim-sulfamethoxazole, all antimicrobials commonly used in the treatment of dairy cattle in Australia. Although highly variable across farms, commensal E. coli isolated from healthy dairy calf feces had significantly higher NWT and multidrug resistance (MDR) prevalence compared with feces from healthy adult lactating dairy cows. The resistant genome identified in MDR isolates, although not always consistent with the phenotype, included QnrS1 and genes encoding AmpC beta-lactamase and aminoglycoside phosphotransferase.
引用
收藏
页码:803 / 820
页数:18
相关论文
共 73 条
[1]   The livestock reservoir for antimicrobial resistance: a personal view on changing patterns of risks, effects of interventions and the way forward [J].
Aarestrup, Frank M. .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2015, 370 (1670)
[2]   Technical specifications on harmonised monitoring of antimicrobial resistance in zoonotic and indicator bacteria from food-producing animals and food [J].
Aerts, Marc ;
Battisti, Antonio ;
Hendriksen, Rene ;
Kempf, Isabelle ;
Teale, Christopher ;
Tenhagen, Bernd-Alois ;
Veldman, Kees ;
Wasyl, Dariusz ;
Guerra, Beatriz ;
Liebana, Ernesto ;
Thomas-Lopez, Daniel ;
Beloeil, Pierre-Alexandre .
EFSA JOURNAL, 2019, 17 (06)
[3]  
AgVic and UoM (Agriculture Victoria and University of Melbourne), 2023, Information for general practitioners working in evacuation centres
[4]   Molecular epidemiology and antimicrobial resistance profiles of Salmonella isolates from dairy heifer calves and adult lactating cows in a Mediterranean pasture-based system of Australia [J].
Aleri, J. W. ;
Sahibzada, S. ;
Harb, A. ;
Fisher, A. D. ;
Waichigo, F. K. ;
Lee, T. ;
Robertson, I. D. ;
Abraham, S. .
JOURNAL OF DAIRY SCIENCE, 2022, 105 (02) :1493-1503
[5]  
[Anonymous], 2023, R Foundation for Statistical Computing (Version 4.1.0)
[6]  
[Anonymous], 2018, AUSVET
[7]  
[Anonymous], 2018, Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark
[8]  
[Anonymous], 1 On 30-day linkage-to-care for new cases of HIV in the United States, and the twice-annual bloodwork recommendations, see, Centers for Disease Control and Prevention, "Understanding the HIV Care Continuum" (Atlanta, GA, June 2018), https://www.cdc.gov/hiv/pdf/library/factsheets/cdc-hiv-care-continuum.pdf
[9]  
See also, World Health Organization, "Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV," September 2015, http://apps.who.int/iris/bitstream/handle/10665/255884/9789241550062-eng.pdf?sequence=1.
[10]  
ASTAG (Australian Strategic and Technical Advisory Group), 2018, Importance ratings and summary of antibacterial uses in human and animal health in Australia, Version 1.0